Continuing Medical Education Information

TARGET AUDIENCE

Endocrinologists, cardiologists, nephrologists, gastroenterologists/liver disease specialists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists.

LEARNING OBJECTIVES

By the end of the meeting, participants will be able to:

  • Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes and metabolism. 
  • Apply new found knowledge to the diagnosis and management of patients with disorders of endocrinology, diabetes or metabolism for improved patient outcomes.  
  • Assess the potential applications of emerging scientific advances that affect the practice of endocrinology.  
  • Explain to your patients the latest clinical treatment options in endocrine health.  

 

ACCREDITATION AND DESIGNATION STATEMENTS

The American College Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.   This activity has been approved for 88.75  AMA PRA Category 1 Credit(s)TM.

Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. 

Disclosure and Conflicts of Interest Policy: 

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.  

 

Faculty - AACE Annual Meeting Program Subcommittee
Chair, 2021 – Elizabeth Pearce, MD, MSc, FACE
Chair Elect, 2022 - Angela M. Leung, MD, MsC, ECNU
Vice Chair – Adriana G. Ioachimescu, MD, PhD, FACE
EC Liaison & President Elect - Felice A. Caldarella, MD, FACP, CDCES, FACE
Ex Officio, President – Howard M. Lando, MD, FACP, FACE
Ex Officio, Chair, Disease State Network Oversight Committee – Dace L. Trence, MD, MACE
Chair, Awards Task Force - Daniel L. Hurley, MD, FACE
Chair, Bone and Parathyroid - Robert A. Wermers, MD, FACE
Chair, Diabetes - Archana R. Sadhu, MD, FACE
Chair, Lipids and CV Health - Scott D. Isaacs, MD, FACP, FACE
Chair, Nutrition and Obesity – Monica Agarwal, MD, FACE
Chair, Pituitary, Gonad, Adrenal and Neuroendocrine - Irina Bancos, MD
Chair, Thyroid - Sina Jasim, MD
Advisor - Christine L. Twining, MD, FACE
Chair, Education Oversight Committee – David C. Lieb, MD, FACE